Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
VASC [NASD]
Vascular Solutions Inc.
Index- P/E38.80 EPS (ttm)0.69 Insider Own0.80% Shs Outstand17.18M Perf Week-2.65%
Market Cap459.91M Forward P/E30.15 EPS next Y0.89 Insider Trans3.00% Shs Float16.37M Perf Month7.08%
Income12.10M PEG1.94 EPS next Q0.18 Inst Own61.90% Short Float2.49% Perf Quarter15.59%
Sales121.60M P/S3.78 EPS this Y8.30% Inst Trans3.93% Short Ratio3.81 Perf Half Y25.92%
Book/sh6.40 P/B4.18 EPS next Y19.52% ROA10.50% Target Price33.13 Perf Year31.42%
Cash/sh2.42 P/C11.06 EPS next 5Y20.00% ROE11.90% 52W Range18.42 - 30.97 Perf YTD15.64%
Dividend- P/FCF29.48 EPS past 5Y-8.40% ROI11.60% 52W High-13.56% Beta0.01
Dividend %- Quick Ratio4.80 Sales past 5Y12.50% Gross Margin67.10% 52W Low45.33% ATR1.09
Employees406 Current Ratio5.90 Sales Q/Q13.90% Oper. Margin16.40% RSI (14)47.61 Volatility3.35% 3.40%
OptionableYes Debt/Eq0.00 EPS Q/Q-6.30% Profit Margin10.00% Rel Volume1.79 Prev Close27.57
ShortableYes LT Debt/Eq0.00 EarningsOct 21 AMC Payout0.00% Avg Volume106.74K Price26.77
Recom1.50 SMA200.04% SMA50-2.14% SMA20010.20% Volume191,245 Change-2.90%
Dec-12-13Reiterated Feltl & Co. Buy $21 → $23
Oct-23-13Reiterated Feltl & Co. Buy $18.75 → $21
Feb-06-13Reiterated Feltl & Co. Buy $16.25 → $18.75
Feb-06-13Reiterated Canaccord Genuity Buy $18.75 → $20.50
Feb-06-13Downgrade The Benchmark Company Buy → Hold $17
Oct-22-12Reiterated Feltl & Co. Buy $15.25 → $16.25
Oct-02-12Reiterated The Benchmark Company Buy $15 → $17
May-08-12Initiated The Benchmark Company Buy $15
Apr-25-12Upgrade Dougherty & Company Neutral → Buy $11.50 → $12.50
Jul-23-10Reiterated Feltl & Co. Buy $12 → $14.50
Jun-24-10Initiated Stifel Nicolaus Buy $16
Mar-04-10Initiated Wedbush Morgan Outperform $12
Oct-21-09Reiterated Caris & Company Above Average $9 → $10
May-21-09Initiated Caris & Company Above Average $9
Feb-05-08Reiterated Canaccord Adams Buy $14 → $11
Jul-20-07Initiated RBC Capital Mkts Outperform
Apr-05-07Initiated Sun Trust Rbsn Humphrey Buy $13
Jan-31-07Reiterated Feltl & Co. Buy $12 → $14
Dec-19-14 08:00AM  Vascular Solutions Announces FDA 510(k) Clearance of ZigiWire(TM) Access Guidewire System GlobeNewswire
Dec-08-14 08:00AM  Vascular Solutions Announces FDA 510(k) Clearance of VSI Radial Introducer Sheath GlobeNewswire
Dec-02-14 08:00AM  Vascular Solutions Completes Purchase of Principal Manufacturing Facility GlobeNewswire
Dec-01-14 08:00AM  Vascular Solutions Receives 510(k) Clearance for Turnpike(TM) Catheters GlobeNewswire
Nov-25-14 01:24PM  Lifshitz & Miller Law Firm Announces Investigation of FireEye, Inc., Hanger Inc., Hertz Global Holdings, Inc., Oplink Communications, Inc., Platinum Underwriters Holdings Ltd., and Vascular Solutions, Inc. PR Newswire
08:00AM  Vascular Solutions Receives 510(k) Clearance for Gel-Block(TM) 10x Embolization Product GlobeNewswire
Nov-20-14 04:06PM  Robbins Arroyo LLP Is Investigating the Officers and Directors of Vascular Solutions, Inc. (VASC) on Behalf of Shareholders PR Newswire
Nov-19-14 04:40PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Vascular Solutions Inc. (VASC) To Contact The Firm PR Newswire
01:56PM  APNewsBreak: Vascular Solutions subsidy scrapped AP
12:12PM  Vascular Solutions Inc. Investors Encouraged to Contact Securities Law Firm about Investigation into Allegations of Corporate Wrongdoing PR Newswire
Nov-18-14 04:05PM  Vascular Solutions to Present at the 26th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-17-14 11:00AM  Vascular Solutions to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum GlobeNewswire
05:42AM  Weakness Seen in Vascular Solutions (VASC): Stock Plunges 22.2% Zacks
Nov-14-14 10:00PM  VASCULAR INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Vascular Solutions Inc. Following Indictment of Company and CEO Business Wire -22.16%
09:09PM  SHAREHOLDER ALERT: Investigation on Behalf of Vascular Solutions, Inc. Investors Announced by Law Offices of Howard G. Smith Business Wire
08:30PM  Harwood Feffer LLP Announces Investigation of Vascular Solutions, Inc. PR Newswire
04:26PM  Ryan & Maniskas, LLP Announces Investigation of Vascular Solutions Inc. PR Newswire
01:34PM  INVESTOR ALERT: Investigation of Vascular Solutions, Inc. Announced by Glancy Binkow & Goldberg LLP Business Wire
11:49AM  EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Class Action Claims Against Vascular Solutions, Inc. Business Wire
10:40AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vascular Solutions, Inc. - VASC PR Newswire
10:39AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vascular Solutions Inc. PR Newswire
Nov-13-14 10:21PM  Federal grand jury indicts Vascular Solutions CEO AP
04:54PM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:09PM  Vascular Solutions Announces $20 Million Share Repurchase Plan GlobeNewswire
04:08PM  Statement of Vascular Solutions on Grand Jury Indictment GlobeNewswire
Nov-06-14 04:05PM  Vascular Solutions to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum GlobeNewswire
Nov-04-14 04:05PM  Vascular Solutions to Present at the 2014 Stifel Nicolaus Healthcare Conference GlobeNewswire
09:00AM  Vascular Solutions to Distribute PolarCath(TM) Peripheral Dilatation System GlobeNewswire
Oct-30-14 10:11AM  Strong And Under The Radar Today: Vascular Solutions (VASC) at TheStreet
Oct-28-14 01:04PM  VASCULAR SOLUTIONS INC Financials EDGAR Online Financials
Oct-21-14 05:31PM  Vascular Solutions posts 3Q profit AP
04:21PM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
04:05PM  Vascular Solutions Reports Third Quarter Results GlobeNewswire
07:07AM  Q3 2014 Vascular Solutions Inc Earnings Release - After Market Close CCBN
Oct-02-14 04:05PM  Vascular Solutions, Inc. to Webcast Third Quarter Conference Call GlobeNewswire
Jul-31-14 06:03AM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Jul-30-14 05:29PM  Vascular Solutions Announces Settlement of Patent Lawsuit With Boston Scientific GlobeNewswire
04:05PM  Vascular Solutions to Present at the 34th Annual Canaccord Genuity Growth Conference GlobeNewswire
Jul-28-14 05:04PM  Vascular Solutions Comments on Justice Department Press Release Concerning Qui Tam Lawsuit Settlement Agreement GlobeNewswire
Jul-23-14 02:06PM  Decoding 4 Stocks' Big Earnings Moves at Motley Fool +10.18%
Jul-22-14 04:24PM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
04:05PM  Vascular Solutions Reports Second Quarter Results GlobeNewswire
07:07AM  Q2 2014 Vascular Solutions, Inc. Earnings Release - After Market Close CCBN
Jul-03-14 05:04PM  Vascular Solutions announces recall of Langston catheters theflyonthewall.com
04:05PM  Vascular Solutions, Inc. Issues Recall of Langston(R) Dual Lumen Catheters GlobeNewswire
Jul-01-14 04:05PM  Vascular Solutions, Inc. to Webcast Second Quarter Conference Call GlobeNewswire
Jun-19-14 04:05PM  Vascular Solutions Launches Gel-Bead(TM) Embolization Spheres GlobeNewswire
May-21-14 07:10AM  Vascular Solutions (VASC) Falls: Stock Goes Down 5.3% Zacks
May-02-14 06:53AM  What Makes Vascular Solutions (VASC) a Strong Sell? Zacks
May-01-14 04:35PM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
04:05PM  Vascular Solutions to Participate in Bank of America Merrill Lynch 2014 Health Care Conference GlobeNewswire
Apr-22-14 09:50PM  Vascular Solutions' CEO Discusses Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
04:30PM  Vascular Solutions, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:29PM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
04:17PM  Vascular Solutions enters into agreement with U.S. Army at theflyonthewall.com
04:05PM  Vascular Solutions Reports First Quarter Results GlobeNewswire
04:03PM  Vascular Solutions Enters Into Agreement With U.S. Army to Develop Freeze-Dried Plasma Product GlobeNewswire
07:07AM  Q1 2014 Vascular Solutions, Inc. Earnings Release - After Market Close CCBN
Apr-16-14 05:50PM  Injunction Lifted on Boston Scientific's Guidezilla Zacks
Apr-15-14 01:03PM  [$$] Court Lifts Injunction Against Boston Scientific at The Wall Street Journal
12:40PM  Injunction lifted on Boston Scientific catheter product Reuters
11:50AM  Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter Vacated by Federal Circuit GlobeNewswire
11:36AM  Injunction lifted on Boston Scientific catheter product Guidezilla Reuters
Apr-09-14 04:05PM  Vascular Solutions Surpasses 50,000 Successfully Reprocessed ClosureFAST(R) Catheters GlobeNewswire
Apr-08-14 04:05PM  Vascular Solutions, Inc. to Webcast First Quarter Conference Call GlobeNewswire
Feb-20-14 04:33PM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
Feb-19-14 04:30PM  Physician Reports Positive 12-Month Clinical Experience and Cost Savings From Use of Reprocessed ClosureFAST(R) Catheters GlobeNewswire
Feb-04-14 10:54PM  Vascular Solutions' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
04:30PM  Vascular Solutions, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:23PM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
04:05PM  Vascular Solutions Reports Record Fourth Quarter Results GlobeNewswire
07:07AM  Q4 2013 Vascular Solutions, Inc. Earnings Release - After Market Close CCBN
Jan-21-14 09:00AM  Vascular Solutions Launches ThrombiDisc(TM) Topical Hemostat in U.S. GlobeNewswire
Jan-14-14 07:42PM  The Story Is Working For AngioDynamics at Seeking Alpha
Jan-13-14 09:00AM  Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter Becomes Effective GlobeNewswire
Jan-07-14 04:05PM  Vascular Solutions, Inc. to Webcast Fourth Quarter Conference Call GlobeNewswire
Dec-11-13 04:05PM  Vascular Solutions Receives Shonin Approvals to Launch GuideLiner(R) Catheter and SuperCross(TM) FT Microcatheter in Japan GlobeNewswire
Dec-09-13 06:02PM  Vascular Solutions Granted Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter GlobeNewswire
Nov-26-13 04:05PM  Vascular Solutions to Present at the 25th Annual Piper Jaffray Health Care Conference GlobeNewswire
Nov-18-13 06:07PM  Vascular Solutions' Management Presents at Barclays Select Growth Conference (Transcript) at Seeking Alpha
Nov-04-13 04:05PM  Vascular Solutions to Present at the Barclays Select Growth Conference GlobeNewswire
Oct-30-13 04:05PM  Vascular Solutions to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum GlobeNewswire
Oct-22-13 10:14PM  Vascular Solutions' CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
04:30PM  Vascular Solutions, Inc. Earnings Call scheduled for 4:30 pm ET today CCBN
04:26PM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
04:25PM  Vascular Solutions, Inc. Discusses Q3 2013 Results (Webcast) at Seeking Alpha
04:05PM  Vascular Solutions Reports Third Quarter Results GlobeNewswire
07:07AM  Q3 2013 Vascular Solutions, Inc. Earnings Release - After Market Close CCBN
Oct-03-13 04:30PM  Vascular Solutions, Inc. to Webcast Third Quarter Conference Call GlobeNewswire
Sep-16-13 04:05PM  Vascular Solutions Surpasses 30,000 Successfully Reprocessed ClosureFAST(R) Catheters GlobeNewswire
Aug-28-13 04:05PM  Vascular Solutions to Present at the 2013 Stifel Nicolaus Healthcare Conference GlobeNewswire
Aug-23-13 10:06AM  Why Vascular Solutions Is Poised to Outperform at Motley Fool
Jul-31-13 04:05PM  Vascular Solutions to Present at the 33rd Annual Canaccord Genuity Growth Conference GlobeNewswire
Jul-26-13 09:20AM  This Metric Suggests You're Right to Own Vascular Solutions. at Motley Fool
Jul-23-13 07:15PM  Vascular Solutions, Inc. (VASC) CEO Discusses Q2 2013 Results - Earnings Call Transcript at Seeking Alpha
06:55PM  Vascular Solutions Earnings: Heres Why Investors are Excited Now at Wall St. Cheat Sheet
04:15PM  InPlay: Vascular Solutions reports EPS in-line, beats on revs; guides Q3 EPS in-line, revs in-line; reaffirms FY13 EPS guidance, raises bottom end of FY13 revs in-line Briefing.com
04:05PM  Vascular Solutions Reports Second Quarter Results GlobeNewswire
09:22AM  VASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Ex EDGAR Online
07:07AM  Q2 2013 Vascular Solutions, Inc. Earnings Release - After Market Close CCBN
Vascular Solutions, Inc., a medical device company, provides various solutions to interventional cardiologists, interventional radiologists, electro physiologists, and vein practices worldwide. The company's catheter products include GuideLiner catheters for deep-seating, back-out support, and optimal stenting in various interventions; Pronto extraction catheters for treating acute myocardial infarction; Micro-Introducers for performing arterial and venous catheterization procedures; Langston to measure intravascular pressure gradients for the diagnosis of aortic valve stenosis; and SmartNeedle, a doppler-guided needle device designed to provide auditory ultrasound-guided access to arteries and veins. It also offers Venture, a deflectable tip catheter used for steering guidewires in various interventions; Guardian, a hemostat valve used in catheterization procedures; SuperCross, a microcatheter for support and delivery of guidewires during coronary and peripheral catheterization procedures; Snares to retrieve or manipulate objects in the cardiovascular system; and Minnie, a support catheter used to facilitate placement and exchange of guidewires and other interventional devices. In addition, the company provides hemostat products comprising D-Stat Dry Thrombix, a thrombin-based hemostat bandage used to control bleeding at the site of femoral artery punctures; D-Stat Flowable, a flowable mixture to control bleeding in the pectoral pockets; Vasc Band radial hemostat, a compression device used to assist with bleeding control; D-Stat Radial, a wrist band to control bleeding at the radial artery access site; and accumed wrist positioning splint. Further, it offers vein products and services, such as Vari-Lase endovenous laser, a laser console and procedure kit used for the treatment of varicose veins, as well as a reprocessing service for the ClosureFAST radiofrequency vein ablation catheter. The company was founded in 1996 and is headquartered in Minneapolis, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NIGON RICHARDDirectorNov 26Buy25.803,00077,40062,279Dec 01 11:00 AM
KRAMP RICHARD WDirectorNov 14Buy23.691,47534,9437,254Nov 14 03:22 PM
Slayton TimothyPrincipal Accounting OfficerApr 24Sale23.151,39032,1799,265Apr 28 04:15 PM
HENNEN JAMESSr. VP of Finance and CFOFeb 27Sale25.255,554140,23950,151Feb 28 04:06 PM
HENNEN JAMESSr. VP of Finance and CFOFeb 26Sale25.634,446113,95155,705Feb 28 04:06 PM
ROOT HOWARDChief Executive OfficerFeb 25Option Exercise9.4648,000454,080493,990Feb 26 04:16 PM
NIGON RICHARDDirectorFeb 25Buy25.661,00025,66058,187Feb 27 04:16 PM
ROOT HOWARDChief Executive OfficerFeb 25Sale24.7048,0001,185,600445,990Feb 26 04:16 PM
ROOT HOWARDChief Executive OfficerFeb 24Option Exercise9.462,00018,920447,990Feb 26 04:16 PM
ROOT HOWARDChief Executive OfficerFeb 24Sale25.612,00051,220445,990Feb 26 04:16 PM
NIGON RICHARDDirectorFeb 20Option Exercise10.8910,000108,90065,187Feb 24 04:13 PM
NIGON RICHARDDirectorFeb 20Sale25.188,000201,44057,187Feb 24 04:13 PM
ROOT HOWARDChief Executive OfficerFeb 14Option Exercise9.463,59534,009449,585Feb 18 04:05 PM
ROOT HOWARDChief Executive OfficerFeb 14Sale24.513,59588,113445,990Feb 18 04:05 PM
ROOT HOWARDChief Executive OfficerFeb 13Option Exercise9.4621,405202,491467,395Feb 18 04:05 PM
ROOT HOWARDChief Executive OfficerFeb 13Sale25.2321,405540,134445,990Feb 18 04:05 PM
O'CONNELL PAULDirectorFeb 11Sale24.432,00048,8604,687Feb 13 10:31 AM
RUTSTEIN WILLIAMSr. VP of Worldwide SalesFeb 10Sale23.7011,666276,48438,425Feb 11 11:19 AM
RUTSTEIN WILLIAMSr. VP of Worldwide SalesFeb 07Sale23.8816,116384,85050,091Feb 11 11:19 AM